Abstract
Lung transplantation is the only effective treatment for end-stage lung disease. The problems, including acute rejection, infection, primary graft dysfunction (PGD) and ischemia/reperfusion injury after lung transplantation, as well as surgical techniques and anesthesia management, donor, cardiopulmonary bypass or extracorporeal membrane oxygenation (ECMO), and the main pathogenesis of the receptor, that restrict the development of lung transplantation seriously, and affect the prognosis of patients. Through the description of above major bottlenecks related to lung transplantation and the factors that seriously affect the survival of lung transplant patients and the current response measures, new ideas for the clinical treatment of lung transplantation are presented.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
